Testing a Reading Module to Improve Reading Skills and Quality of Life in Glaucoma Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorUniversiti Sains Malaysia

About this trial

The goal of this interventional study is to test the effectiveness of reading rehabilitation module towards reading speed and error, and quality of life in glaucoma patients.The main questions it aims to answer are:

1. Is there a significant difference in reading speed over a 6-month period between glaucoma patients who undergo a reading rehabilitation module and those who receive standard care? 2. To what extent does the implementation of a reading rehabilitation module reduce the frequency of reading errors in glaucoma patients compared to a control group across baseline, 3-month, and 6-month follow-ups? 3. How does a structured reading rehabilitation module influence the self-reported quality of life in glaucoma patients from baseline to 6 months when compared to those receiving standard care?

Participants will:

Patients in interventional group will be instructed to practice the reading module for 20-30 minutes daily, minimum 3 days/week, for 6 months.

Visit the clinic once every 3 months for checkups and tests A logbook will be provided to record their practice sessions.

While participants in control group will receive standard care, visit the clinic once every 3 months for checkups and tests.

Eligibility criteria

Qualifiers

Age 18- 80 years old.

Confirmed diagnosis of bilateral Primary Open Angle Glaucoma (POAG),Primary Angle Closure Glaucoma (PACG), Normotensive Glaucoma (NTG) and Juvenile Open Angle Glaucoma (JOAG).

Bilateral visual acuity of 6/60 and better.

Bilateral visual field defect more than 10degree from fixation.

Disqualifiers

Ocular diseases other than glaucoma (e.g., age-related macula degeneration, diabetic retinopathy, moderate to severe cataract).

Other comorbidities that affect memory (e.g., stroke, cognitive disorders).

Cognitive disorders (e.g., diagnosed dementia or cognitive impairment).

Poorly controlled diabetes mellitus, hypertension and hyperlipidaemia.

Trial design

Treatments tested in this trial

  • Reading Rehabilitation Module

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators